Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Vaccine trial for equine grass sickness
Study in preparation for a nationwide vaccine trial

It has been announced that the Animal Health Trust (AHT) and the Royal (Dick) School of Veterinary Studies of the University of Edinburgh, will be conducting a small pilot vaccine trial to protect against equine grass sickness.

Following approval by the Veterinary Medicines Directorate, the pilot study is set to take place in eastern Scotland, since equine grass sickness was first reported in the region more than a century ago.

The pilot study is in preparation for a full nationwide vaccine trial involving at least 1000 horses and ponies. This will likely commence in 2014, but is subject to securing sufficient funding.

The Equine Grass Sickness Fund is leading a campaign in order to raise money for the full vaccine trial.

The AHT has great hopes that these vaccine trials will mark an enormous breakthrough in the prevention of the disease. Although there is still a lot of work to do before launching the full nationwide vaccine trial, this initial pilot study will help to ensure that the trial design will be practical to perform on a larger scale.

Kate Thomson, spokesperson for the Equine Grass Sickness Fund, said: "We are over the moon that the pilot vaccine trial has begun, but fundraising now starts in earnest to ensure that the full trial can go ahead.

"Grass sickness brings about a devastating annual toll, and we are appealing to every horse owner in the UK to help bring an end to this disease by donating to this cause."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.